Tag: Clover Biopharmaceuticals

September 29, 2019 Off

Clover Biopharmaceuticals doses first patient in phase I study of SCB-313 in China for Malignant Ascites

CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first…

September 10, 2019 Off

Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Peritoneal Carcinomatosis

By BusinessWire

BEIJING–(BUSINESS WIRE)–Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient…